DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,804,745 | +4.8% | 75,795 | +1.3% | 1.64% | +8.7% |
| Q2 2023 | $17,949,999 | -1.2% | 74,792 | +3.8% | 1.51% | -9.1% |
| Q1 2023 | $18,169,117 | -1.3% | 72,088 | +4.0% | 1.66% | -8.3% |
| Q4 2022 | $18,399,447 | +3.3% | 69,322 | +0.5% | 1.82% | -1.9% |
| Q3 2022 | $17,818,000 | +2.8% | 68,985 | +0.9% | 1.85% | +11.2% |
| Q2 2022 | $17,327,000 | -11.5% | 68,344 | +2.4% | 1.66% | +5.2% |
| Q1 2022 | $19,572,000 | -10.7% | 66,723 | +0.2% | 1.58% | -6.8% |
| Q4 2021 | $21,907,000 | +7.9% | 66,584 | -0.2% | 1.70% | -2.6% |
| Q3 2021 | $20,309,000 | +14.0% | 66,710 | +0.5% | 1.74% | +13.6% |
| Q2 2021 | $17,818,000 | +20.9% | 66,397 | +1.4% | 1.54% | +12.3% |
| Q1 2021 | $14,739,000 | +3.5% | 65,485 | +2.2% | 1.37% | +1.9% |
| Q4 2020 | $14,240,000 | -9.5% | 64,105 | -12.2% | 1.34% | -21.5% |
| Q3 2020 | $15,729,000 | +21.5% | 73,044 | -0.2% | 1.71% | +8.4% |
| Q2 2020 | $12,946,000 | +11.2% | 73,210 | -13.0% | 1.58% | -9.8% |
| Q1 2020 | $11,646,000 | -16.4% | 84,138 | -7.3% | 1.75% | +5.1% |
| Q4 2019 | $13,929,000 | +19.3% | 90,758 | +12.3% | 1.66% | +14.3% |
| Q3 2019 | $11,673,000 | +1.4% | 80,818 | +0.3% | 1.46% | +0.1% |
| Q2 2019 | $11,512,000 | +6.8% | 80,546 | -1.4% | 1.45% | +2.5% |
| Q1 2019 | $10,780,000 | -9.2% | 81,656 | -29.0% | 1.42% | -23.5% |
| Q4 2018 | $11,866,000 | -3.9% | 115,071 | +1.2% | 1.86% | +14.7% |
| Q3 2018 | $12,351,000 | +14.4% | 113,665 | +3.9% | 1.62% | +2.8% |
| Q2 2018 | $10,793,000 | +3.3% | 109,378 | +2.5% | 1.57% | +3.4% |
| Q1 2018 | $10,453,000 | +5.4% | 106,762 | -0.1% | 1.52% | +5.5% |
| Q4 2017 | $9,917,000 | +9.8% | 106,846 | +1.5% | 1.44% | +2.6% |
| Q3 2017 | $9,032,000 | +132.3% | 105,291 | +128.6% | 1.41% | +115.6% |
| Q2 2017 | $3,888,000 | +3.5% | 46,069 | +4.9% | 0.65% | -7.0% |
| Q1 2017 | $3,755,000 | – | 43,902 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |